tiprankstipranks
Trending News
More News >
AlzeCure Pharma AB (DE:AC6)
:AC6
Germany Market

AlzeCure Pharma AB (AC6) Income Statement

Compare
2 Followers

AlzeCure Pharma AB Income Statement

Last quarter (Q1 2025), AlzeCure Pharma AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q1, AlzeCure Pharma AB's net income was kr-10.11M. See AlzeCure Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr 0.00kr -476.00Kkr -570.00Kkr -576.00Kkr -495.00K
Operating Expenses
kr 36.14Mkr 38.26Mkr 56.57Mkr 78.14Mkr 72.02M
Depreciation and Amortization
kr 293.00Kkr 476.00Kkr 570.00Kkr 576.00Kkr 495.00K
EBITDA
kr -35.70Mkr -37.87Mkr -55.67Mkr -77.20Mkr -70.87M
Operating Income
kr -36.14Mkr -38.26Mkr -56.44Mkr -77.93Mkr -71.58M
Other Income/Expenses
kr 910.00Kkr 1.09Mkr 203.00Kkr 145.00Kkr 213.00K
Pretax Income
kr -35.23Mkr -37.17Mkr -56.24Mkr -77.78Mkr -71.37M
Net Income
kr -35.23Mkr -37.17Mkr -56.04Mkr -77.78Mkr -71.37M
Per Share Metrics
Basic EPS
kr -0.46kr -0.60kr -1.17kr -1.98kr -1.82
Diluted EPS
kr -0.46kr -0.60kr -1.17kr -1.98kr -1.82
Weighted Average Shares Outstanding
76.59M 61.95M 47.70M 39.32M 39.32M
Weighted Average Shares Outstanding (Diluted)
77.15M 62.09M 47.70M 39.32M 39.32M
Currency in SEK

AlzeCure Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis